Precision BioSciences Inc (DTIL)
9.60
-0.12
(-1.23%)
USD |
NASDAQ |
Apr 26, 12:07
Precision BioSciences Total Assets (Quarterly): 159.78M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 159.78M |
| September 30, 2023 | 164.34M |
| June 30, 2023 | 181.70M |
| March 31, 2023 | 204.50M |
| December 31, 2022 | 238.17M |
| September 30, 2022 | 271.73M |
| June 30, 2022 | 297.16M |
| March 31, 2022 | 181.35M |
| December 31, 2021 | 211.50M |
| September 30, 2021 | 227.20M |
| June 30, 2021 | 230.11M |
| Date | Value |
|---|---|
| March 31, 2021 | 262.32M |
| December 31, 2020 | 150.16M |
| September 30, 2020 | 168.69M |
| June 30, 2020 | 184.19M |
| March 31, 2020 | 214.20M |
| December 31, 2019 | 235.23M |
| September 30, 2019 | 260.30M |
| June 30, 2019 | 271.92M |
| March 31, 2019 | 166.80M |
| December 31, 2018 | 138.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
150.16M
Minimum
Dec 2020
297.16M
Maximum
Jun 2022
216.56M
Average
214.20M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Altimmune Inc | 210.64M |
| BioVie Inc | 21.49M |
| Adial Pharmaceuticals Inc | 4.737M |
| Gritstone Bio Inc | 177.77M |
| Humacyte Inc | 128.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 140.92M |
| Shareholders Equity (Quarterly) | 18.86M |
| Debt to Equity Ratio | 1.188 |
| Current Ratio | 2.728 |
| Net Debt Paydown Yield | -0.10% |